After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, CDNA falls under the Healthcare sector while operating within the Diagnostics & Research industry segment. The current market capitalization of Caredx Inc is $780.84M. A total of 0.75 million shares were traded on the day, compared to an average of 1.33M shares.
In the most recent transaction, Novack Jeffrey Adam sold 2,688 shares of CDNA for 12.79 per share on Aug 05 ’25. After the transaction, the Secretary and General Counsel now owns 112,930 company shares. In a previous transaction on Aug 05 ’25, Jeffrey Adam Novack bought 2,688 shares at 12.60 per share.
Among the insiders who sold shares, Maag Peter disposed of 10,000 shares on Jul 07 ’25 at a per-share price of $18.58. This resulted in the Director holding 308,846 shares of CDNA after the transaction. In another insider transaction, Valantine Hannah sold 10,570 shares at $19.16 per share on Jun 18 ’25. Company shares held by the Director now total 38,994.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CDNA has a high of $26.37 and a low of $10.96.
As of this writing, CDNA has an earnings estimate of $0.14 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $0.17 per share and a lower estimate of $0.12. The company reported an EPS of $0.14 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CDNA’s latest balance sheet shows that the firm has $348.49M in Cash & Short Term Investments as of fiscal 2021. There were $21.35M in debt and $77.30M in liabilities at the time. Its Book Value Per Share was $6.15, while its Total Shareholder’s Equity was $465.88M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDNA is Buy with a score of 3.67.
